Mitesh Thakkar: BUY Piramal Enterprises, Dalmia Bharat, MGL and Divis

Neeta Aurora 4 November 2022
Mitesh Thakkar: BUY Piramal Enterprises, Dalmia Bharat, MGL and Divis

Market analyst Mitesh Thakkar has suggested two BUY Calls and two SELL Calls for today’s trading session.

Shrikant Chouhan: BUY Reliance and Dr Reddy’s

Sukant Sharma 4 November 2022
Shrikant Chouhan: BUY Reliance and Dr Reddy’s

Market expert Shrikant Chouhan from Kotak Securities has suggested two BUY Calls and no SELL Call for today’s trading session. Indian markets are expected to open slightly lower.

Ford pushes back EV sales program deadline to December 31, 2022

Gaurav Mehra 4 November 2022
Ford pushes back EV sales program deadline to December 31, 2022

American automobile giant Ford Motor Company has pushed back deadline for its dealers by a month to decide whether they will opt in to the program that requires investments of more than $1 million

Ashish Chaturvedi: BUY Just Dial, Andhra Paper; SELL Hind Copper and TVS Motor Company

Kunal Singh 3 November 2022
Ashish Chaturvedi: BUY Just Dial, Andhra Paper; SELL Hind Copper and TVS Motor Company

Market expert Ashish Chaturvedi has suggested two BUY Calls and two SELL Calls for today’s trading session.

Varun Dubey: BUY Bajaj Auto, Anand Rathi; SELL Wipro and Biocon

Karan Kapoor 3 November 2022
Varun Dubey: BUY Bajaj Auto, Anand Rathi; SELL Wipro and Biocon

Market expert Varun Dubey has suggested two BUY Calls and two SELL Calls for today’s trading session. Indian markets are expected to open flat today and we could see selling at higher levels.

Sudarshan Sukhani: BUY UltraTech Cement; SELL Biocon, M&M Financial and PNB

Sukant Sharma 3 November 2022
Sudarshan Sukhani: BUY UltraTech Cement; SELL Biocon, M&M Financial and PNB

Technical analyst Sudarshan Sukhani has suggested one BUY Call and three SELL Calls for today’s trading session.

Pages

News in Focus

Hindalco Industries Share Price Target at Rs 735: Kotak Institutional Equities
Hindalco Industries Share Price Target at Rs 735: Kotak Institutional Equities
Featured, Analyst View, Hindalco, India, Kotak Securities, Metals Sector

Hindalco Industries continues to demonstrate strategic resilience and operational superiority across its core verticals.

Interglobe Aviation (Indigo) Share Price Target at Rs 6,377: ICICI Securities
Interglobe Aviation (Indigo) Share Price Target at Rs 6,377: ICICI Securities
Featured, Analyst View, Aviation Sector, ICICI Securities, India, Indigo Airlines

IndiGo’s Q4 FY25 results have reinforced investor optimism, prompting ICICI Securities to maintain its BUY call on InterGlobe Aviation with an upgraded target price of Rs. 6,377 (previously Rs.

Power Grid Corporation Share Price Target at Rs 361: ICICI Securities
Power Grid Corporation Share Price Target at Rs 361: ICICI Securities
Featured, India Business, Analyst View, ICICI Securities, Power Grid, Power Sector

Power Grid Corporation of India (PGCIL) has drawn a fresh vote of confidence from ICICI Securities, which has maintained its BUY rating with a 12-month target price of Rs 361, implying a potential

ITC Share Price Could Reach Rs 538: Prabhudas Lilladher Research
ITC Share Price Could Reach Rs 538: Prabhudas Lilladher Research
Featured, Analyst View, Stock Markets, FMCG Sector, India, ITC, Prabhudas Lilladher

ITC Ltd has received an upgrade from Prabhudas Lilladher, with the research house elevating its rating to BUY and revising the target price to Rs 538 from the previous Rs 524.

IndusInd Bank Share Price Target at Rs 737: LKP Research Downgrades Stock
IndusInd Bank Share Price Target at Rs 737: LKP Research Downgrades Stock
Featured, Analyst View, Banking Sector, India, Indusind Bank, LKP Securities

IndusInd Bank has encountered one of its most turbulent quarters in recent memory, and LKP Research has acted swiftly in response, slashing its rating to REDUCE and assigning a revised 12-month tar

Sun Pharmaceutical Share Price Target at Rs 2,000: Motilal Oswal Research
Sun Pharmaceutical Share Price Target at Rs 2,000: Motilal Oswal Research
Featured, Analyst View, India, Motilal Oswal, Pharmaceutical Sector, Sun Pharmaceutical

Motilal Oswal has reiterated a BUY recommendation on Sun Pharma, assigning a target price of Rs 2,000, implying a 16% upside from its current market price of Rs 1,719.